Detailed price information for Pliant Therapeutics Inc (PLRX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Serve Robotics Inc (SERV-Q) from The Globe and Mail including charting and trades.

The RealReal, Inc. (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—today ...

Last patient visit completed in Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis; topline results expected in ...

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases ...

Revenue of $61 million, up 49%52%Member Growth and Significant Progress Toward Profitability SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) --  Omada Health, Inc. (Nasdaq: OMDA), the virtual ...

Embecta Corp. ("embecta" or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and nine ...

Quarter Sales of $191.9 million, up 74% from a year earlier, Quarter Net Income of $51.2 million, up 138% from a year earlier, Diluted EPS $2.22 for the Quarter, up 136% from a year earlier, ...

Interest expense was $53.7 million for the quarter ended June 30, 2025, compared to $37.9 million for the quarter ended June 30, 2024. The higher expenses were primarily driven by the increases in ...

Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, today announced financial ...

Second Quarter Pre-Tax Income of $94.4 million and Diluted EPS of $5.18 Book Value Per Share Increased to $58.55 Gross Loss Ratio of 21.3% ...

Improved second quarter 2025 net loss by 18% to $ (17.4) million compared to $ (21.2) million in the same period in 2024. Improved adjusted EBITDA by 58% to $ (3.6) million in the second quarter 2025 ...